Literature DB >> 6989048

Advantages of low dose steroid from the day after renal transplantation.

M G McGeown, J F Douglas, W A Brown, R A Donaldson, J A Kennedy, W G Loughridge, S Mehta, S D Nelson, C C Doherty, R Johnstone, G Todd, C M Hill.   

Abstract

We have used a low dose of steroid (20 mg of prednisolone), commencing the day after transplantation, for 151 consecutive renal transplants in 141 patients. Five patients received grafts from living related donors, 146 received cadaver grafts. All patients received azathioprine for routine immunosuppression and the first 47 received a single dose of actinomycin C i.v. for treatment of rejection. No other immunosuppressive drugs were used. This treatment provided satisfactory immunosuppression as 109 of 151 grafts continue to function for periods of 3 months to 10 years and, of 42 grafts lost, only 17 failed from rejection. The cumulative survival of first cadaver grafts at 1 and 2 years in recipients of all ages (7 to 55 years) was 77.9 and 76.0%, respectively; in recipients 15 to 34 years old, 90.9 and 86.1%, respectively. Twenty-three patients died, no patient died from infection during the admission for transplantation, and infection played a part in the deaths of only four patients. The incidence of other complications was low; seven patients developed gastrointestinal complications, one died, four patients developed diabetes, all survived; only one patient developed avascular necrosis of bone.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6989048     DOI: 10.1097/00007890-198004000-00005

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  13 in total

1.  The late results of renal transplantation and the importance of chronic rejection as a cause of graft loss.

Authors:  M C Foster; P W Wenham; P A Rowe; R P Burden; A G Morgan; R E Cotton; R W Blamey
Journal:  Ann R Coll Surg Engl       Date:  1989-01       Impact factor: 1.891

2.  Effect of cimetidine on upper gastrointestinal bleeding after renal transplantation.

Authors:  C Doherty
Journal:  Br Med J (Clin Res Ed)       Date:  1984-12-01

3.  Regional kidney sharing program for patients with broadly reactive lymphocytotoxic antibodies.

Authors:  D J Norman; J M Barry; B A VanderWerf
Journal:  West J Med       Date:  1982-02

Review 4.  Corticosteroid avoidance in pediatric renal transplantation: can it be achieved?

Authors:  Jayakumar R Vidhun; Minnie M Sarwal
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

5.  Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. The Canadian Multicentre Transplant Study Group.

Authors:  N R Sinclair
Journal:  CMAJ       Date:  1992-09-01       Impact factor: 8.262

6.  Long-term immunosuppression, without maintenance prednisone, after kidney transplantation.

Authors:  Arthur J Matas; Raja Kandaswamy; Abhinav Humar; William D Payne; David L Dunn; John S Najarian; Rainer W G Gruessner; Kristen J Gillingham; Lois E McHugh; David E R Sutherland
Journal:  Ann Surg       Date:  2004-09       Impact factor: 12.969

7.  Long term outcome of renal transplantation in the pre cyclosporin era: one centre's experience.

Authors:  P J Conlon; W Medwar; S Hanson; J Donohoe; M Carmody; J J Walshe
Journal:  Ir J Med Sci       Date:  1995 Apr-Jun       Impact factor: 1.568

8.  Characteristics of cadaveric renal allograft recipients developing chronic rejection.

Authors:  M C Foster; P A Rowe; M J Dennis; A G Morgan; R P Burden; R W Blamey
Journal:  Ann R Coll Surg Engl       Date:  1990-01       Impact factor: 1.891

Review 9.  The gastrointestinal tract in uremia.

Authors:  J Y Kang
Journal:  Dig Dis Sci       Date:  1993-02       Impact factor: 3.199

Review 10.  Endocrine and metabolic abnormalities following kidney transplantation.

Authors:  W H Hörl; W Riegel; C Wanner; M Haag-Weber; P Schollmeyer; H Wieland; H Wilms
Journal:  Klin Wochenschr       Date:  1989-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.